◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksU › UFPT

UFP Technologies Inc (UFPT) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · MEDICAL DEVICES · DATA UPDATED 2026-09-05

UFP Technologies Inc (UFPT) operates in the MEDICAL DEVICES industry and is headquartered in Newburyport, United States with about 4,846 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, UFPT reported $603M in revenue and $68M in net income.

UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.

Interactive charts & full statements → Open the UFPT valuation workbench →

UFPT Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Revenue$632M$603M$504M$400M$354M$206M$179M$198M$190M$148M$146M$139M$139M$139M$131M$127M$121M$99M$110M$94M$94M
Gross Profit$180M$170M$147M$112M$90M$51M$45M$54M$48M$35M$35M$37M$37M$41M$38M$36M$35M$27M$29M$23M$19M
Gross Margin %28.5%28.3%29.1%28.1%25.5%24.8%24.9%27.2%25.4%24.0%23.7%27.0%26.5%29.2%29.2%28.5%28.7%26.9%26.0%24.4%20.5%
Operating Income (EBIT)$96M$92M$81M$58M$55M$21M$17M$25M$20M$12M$12M$12M$12M$17M$17M$16M$14M$8M$8M$7M$5M
Operating Margin %15.2%15.3%16.0%14.4%15.7%10.3%9.3%12.4%10.3%7.9%8.4%8.4%8.3%12.5%12.7%12.3%11.9%8.2%7.7%7.7%5.4%
Net Income$72M$68M$59M$45M$42M$16M$13M$20M$14M$9M$8M$8M$8M$11M$11M$10M$9M$6M$5M$4M$3M
Net Margin %11.5%11.3%11.7%11.2%11.8%7.7%7.4%10.0%7.5%6.2%5.5%5.5%5.4%8.1%8.3%8.1%7.7%6.0%4.7%4.4%2.7%
EBITDA$115M$116M$96M$69M$67M$30M$25M$32M$28M$17M$18M$18M$17M$21M$20M$18M$17M$11M$11M$10M$8M
Earnings Per Share (EPS)$9.27$8.75$7.58$5.83$5.45$2.09$1.77$2.63$1.93$1.26$1.10$1.05$1.05$1.59$1.55$1.48$1.37$0.94$0.82$0.71$0.45
Shares Outstanding (M)8M8M8M8M8M8M8M8M7M7M7M7M7M7M7M7M7M6M6M6M6M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UFPT Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$174M$154M$149M$155M$151M$148M$144M$145M
Gross Profit$51M$44M$42M$43M$44M$42M$42M$42M
Gross Margin %29.3%28.8%28.2%27.7%28.8%28.4%29.2%28.6%
Operating Income (EBIT)$28M$23M$22M$23M$24M$23M$22M$25M
Operating Margin %16.2%15.1%14.4%15.1%16.1%15.6%15.4%17.1%
Net Income$21M$17M$18M$16M$17M$17M$16M$16M
Net Margin %12.0%11.3%11.8%10.6%11.4%11.6%11.4%11.3%
EBITDA$28M$28M$31M$28M$29M$28M$27M$29M
Earnings Per Share (EPS)$2.67$2.24$2.25$2.11$2.21$2.21$2.10$2.11
Shares Outstanding (M)8M8M8M8M8M8M8M8M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UFPT Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Cash from Operations (CFO)$72M$92M$67M$41M$18M$14M$25M$31M$21M$17M$9M$13M$11M$16M$16M$12M$13M$11M$7M$10M$12M
Capital Expenditures (CapEx)$10M$13M$10M$10M$14M$5M$4M$6M$5M$10M$7M$16M$13M$6M$12M$4M$3M$2M$3M$2M$2M
Free Cash Flow (FCF)$61M$79M$57M$31M$4M$9M$21M$25M$16M$7M$2M($3M)($2M)$10M$4M$8M$9M$9M$4M$8M$11M
FCF Margin %9.7%13.1%11.3%7.7%1.1%4.3%11.5%12.8%8.3%4.8%1.4%-2.3%-1.7%7.4%3.2%6.3%7.7%8.9%3.6%8.6%11.3%
Dividends Paid$2M$2M$1M$0M$0M$0M$0M$0M$0M$1M$0M$0M$0M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UFPT Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$16M$3M$17M$36M$25M$14M$24M$20M
Capital Expenditures (CapEx)$1M$2M$4M$3M$3M$3M$3M$2M
Free Cash Flow (FCF)$14M$1M$13M$33M$22M$11M$21M$18M
FCF Margin %8.3%0.9%8.7%21.1%14.9%7.4%14.9%12.2%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

UFPT Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-31
Total Assets$682M$666M$629M$404M$378M$334M$203M$189M$190M$138M$128M$120M$114M$105M$99M$80M$72M$59M$49M$46M$39M
Cash & Cash Equivalents$9M$20M$13M$5M$4M$11M$24M$4M$3M$38M$31M$30M$34M$37M$33M$30M$24M$15M$7M$9M$1M
Total Liabilities$219M$242M$286M$118M$141M$140M$26M$27M$49M$14M$15M$16M$19M$19M$25M$18M$22M$20M$17M$21M$20M
Total Debt (Short + Long-Term)$122M$140M$194M$35M$58M$77M$1M$1M$25M$0M$1M$2M$3M$4M$10M$6M$8M$8M$6M$8M$9M
Total Shareholders' Equity$462M$424M$343M$286M$238M$194M$177M$162M$140M$124M$113M$104M$95M$86M$73M$61M$50M$39M$31M$24M$19M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive UFPT viewer.

Other Companies in MEDICAL DEVICES

← UFPIAll “U” companiesUFSD →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.